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There is now considerable scientific evidence that a diet rich in fruits and vegetables could 
improve human health (1). However, it is not clear whether different fruits and vegetables 
have different beneficial effects. Apples are a rich source of polyphenols and fiber and are 
widely consumed worldwide (2). An important proportion of these bioactive compounds in 
apples escape digestion in the upper intestinal tract and reach the colon where they can be 
fermented by the colonic microbiota (3). Preliminary results from our group have shown that 
apples - Gold Rush, Renetta Canada, Golden Delicious and Pink Lady - may beneficially 
increase the bifidobacteria levels in in vitro batch culture models with the Renetta Canada 
variety showing the most beneficial effects (Figure 1).  
 
Figure 1. Bifidobacteria bacterial populations (log10 cells/ml batch culture fluid) determined by fluorescence in 
situ hybridisation (FISH) and quantitative polymerase chain reaction (qPCR) in anaerobic, stirred, pH and 
temperature controlled faecal batch cultures at 0, 5, 10 and 24 h using inulin as a positive control, cellulose as 
negative control and blank vessel (only faeces) as a baseline in order to compare the microbiota-modulating 
abilities of 4 different apple varieties (n=3 healthy adults).	  Results are the difference between T0 and T24. Bars 
represent the mean of triplicate, error bars represent SD. 
	  
Based on these results we are currently performing a randomized, controlled, crossover, 
dietary human intervention study -the AVAG study- which explores the hypothesis that a 
daily consumption of 2 apples for 8 weeks can decrease the risk of cardiovascular disease by 
reducing total cholesterol levels, improving vascular function and beneficially modulating gut 
microbiota in 40 mild hypercholesterolaemic subjects. The dietary intervention part of the 
study will finish in September, 2014 and the following analysis includes the determination of 
the gut microbiota population using FISH and 454 pyrosequencing of community based 16-S 
ribosomal RNA genes and metabolomic analysis of the low molecular weight metabolite 
profiles in the biological fluids (blood, urine and faecal sample). Moreover, the determination 
of several markers of cardiovascular health including blood lipid, glucose and insulin levels, 
inflammatory and endothelial function markers and assessment of vascular function using 
Laser Doppler Iontophoresis and Pulse Wave Analysis will be performed.  
This trial is registered at http://clinicaltrials.gov/show/NCT01988389. 
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